Shockwave Medical names Renee Gaeta CFO, replacing retiring Dan Puckett

Shockwave Medical, Inc.

Renee Gaeta appointed CFO effective Feb 5, 2024; previously CFO at Eko Health and Establishment Labs.
Dan Puckett resigns as CFO, will consult through Feb 2025; receives $20k/month for first 8 months, then $10k/month.
Gaeta's compensation: $500k base salary, 60% target bonus, and $4.5M in RSUs vesting over 4 years.
Gaeta serves on board and audit committee of Candel Therapeutics since Aug 2022.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Daniel Puckett

Chief Financial Officer

Shockwave Medical, Inc.

Effective: 2024-02-05
Successor: Renee Gaeta
Filed: January 29, 2024, 6:59 PM ET

On January 29, 2024, Daniel Puckett resigned as Chief Financial Officer of the Company, effective as of the Effective Date.

Appointed

Renee Gaeta

Chief Financial Officer

Shockwave Medical, Inc.

Effective: 2024-02-05
Filed: January 29, 2024, 6:59 PM ET

On January 28, 2024, the board of directors of Shockwave Medical, Inc. (the “Company”) appointed Renee Gaeta as Chief Financial Officer and to act as the Company’s principal financial officer for Securities and Exchange Commission (“SEC”) reporting purposes, effective as of February 5, 2024 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel Puckett resigned as Chief Financial Officer at Shockwave Medical, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On January 29, 2024, Daniel Puckett resigned as Chief Financial Officer of the Company, effective as of the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Renee Gaeta was appointed as Chief Financial Officer at Shockwave Medical, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On January 28, 2024, the board of directors of Shockwave Medical, Inc. (the “Company”) appointed Renee Gaeta as Chief Financial Officer and to act as the Company’s principal financial officer for Securities and Exchange Commission (“SEC”) reporting purposes, effective as of February 5, 2024 (the “Effective Date”).

View on SEC.gov

Source: SEC EDGAR

accession 0001642545-24-000016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.